• Product NameEfaproxiral Sodium
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityEfaproxiral Sodium is a synthetic allosteric modifier of hemoglobin, used for brain metastases originating from breast cancer.
• Target NameOthers
• CAS No. 170787-99-2
• Calculated MW 363.38
• Formulation C20H23NO4.Na
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Other
  SMILES:[Na+].CC1=CC(NC(=O)CC2=CC=C(OC(C)(C)C([O-])=O)C=C2)=CC(C)=C1 |c:19,21,24,t:1,8,10|
  Pathways:Others
  Receptor:Others
  Boling pt:
  Melting pt:
  Solubility:DMSO:73 mg/mL (200.89 mM)Ethanol:73 mg/mL (200.89 mM)Water:73 mg/mL (200.89 mM)
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Donnelly ET, et al. Exp Biol Med (Maywood), 2006, 231(3), 317-321.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting